MedPath

Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery

Not Applicable
Completed
Conditions
Low Anterior Resection Syndrome
Interventions
Drug: Medication
Device: Transanal irrigation
Registration Number
NCT03215017
Lead Sponsor
Mirna Abraham-Nordling
Brief Summary

A randomized controlled trial (RCT) in patients who underwent sphincter preserving surgery due to rectal cancer. The study will analyze the effect of Transanal irrigation (TAI) and medication that can help control of the bowel movement in patients with low anterior resection syndrome.

Detailed Description

A randomized controlled trial (RCT) in patients who underwent sphincter preserving surgery due to rectal cancer.

The study will analyze the effect of Transanal irrigation (TAI) and medication that can help control of the bowel movement in patients with low anterior resection syndrome.

An interim analysis will be made after 40 included patients in the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Patients that have undergone surgery for rectal cancer (sphincter saving surgery, low anterior resection)
  • Adult ≥ 18 years old
  • Have scoring major LARS (according to the Low anterior resection syndrome score)
Exclusion Criteria
  • stoma
  • recurrent disease
  • Another colorectal surgery
  • Inflammatory bowel disease (IBD)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MedicationMedicationMedication to control bowel function.
Transanal irrigationTransanal irrigationManual transanal irrigation to control bowel function.
Primary Outcome Measures
NameTimeMethod
Bowel function1 year

Cleveland incontinence questionnaire

Bowel function, Low anterior resection syndrome (LARS)1 year

Assessed using LARS questionnaire (score 0-42, a high score indicates poor bowel function)

Secondary Outcome Measures
NameTimeMethod
Quality of Life (QoL)1 year

Assessed using EORTC Quality of life questionnaire (QLQ)-C30

Trial Locations

Locations (3)

Karolinska University Hospital

🇸🇪

Stockholm, Sweden

Stockholm South General Hospital

🇸🇪

Stockholm, Sweden

Danderyd Hospital

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath